Sands Capital Closes $560M Life Sciences Fund
- Sands Capital held a first and final closing of its second life sciences dedicated fund, SandsCapital Life Sciences Pulse Fund II, L.P., raising $560m
- This close increases total Pulse Strategy assets under management to more than $950m
- The team will continue investing with the same focus on private therapeutics, diagnostics, and life sciences tools businesses
- Since launching Pulse I in 2018, the Pulse Strategy has invested in 20 businesses while continuing to build its investment, operations, and client relations teams
- SandsCapital is an independent, staff-owned firm founded in 1992 with offices in the Washington, D.C. area, San Francisco, and Singapore
- The firm provides growth capital solutions to institutions and fund sponsors in more than 40 countries
